Omnimmune Holdings (merged with Roughneck) Overview

  • Status
  • Public

  • Employees
  • 2

  • Stock Symbol
  • OMMH

Stock Symbol

Omnimmune Holdings (merged with Roughneck) General Information


Omnimmune Holdings Inc is a development-stage biotechnology company, which is engaged in integrating complementary cancer therapeutic, diagnostic and prognostic technologies.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Stock Exchange
Primary Office
  • 4550 Post Oak Place Drive
  • Suite 224
  • Houston, TX 77027
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Omnimmune Holdings (merged with Roughneck) Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS

Omnimmune Holdings (merged with Roughneck) Financials Summary

In Thousands,
TTM 30-Sep-2010 FY 2009 31-Dec-2009 FY 2008 31-Dec-2008 FY 2007 31-May-2007
EV 2,592 3,694 5,289
Revenue 0 0 0
EBITDA (884)
Net Income (1,794) (1,761) (5,990) (9)
Total Assets 44 31 53 74
Total Debt 2,285 2,273 2,257
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Omnimmune Holdings (merged with Roughneck) Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Omnimmune Holdings (merged with Roughneck)‘s full profile, request access.

Request a free trial

Omnimmune Holdings (merged with Roughneck) Executive Team (3)

Name Title Board Seat Contact Info
Harris Lichtenstein Chief Executive Officer, President, Director & Chief Financial Officer
Harris Lichtenstein Chief Executive Officer & Chief Financial Officer, Finance
You’re viewing 2 of 3 executive team members. Get the full list »

Omnimmune Holdings (merged with Roughneck) Board Members (1)

Name Representing Role Since
0000 0000000 Self Chairman & Board Member 000 0000
To view Omnimmune Holdings (merged with Roughneck)’s complete board members history, request access »

Omnimmune Holdings (merged with Roughneck) Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial